SCHEMBL25580293

SCHEMBL25580293

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccccc2N(c2ccc3ccccc3c2)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ HPGD P15428 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580253 0.94 ANO1 (0.33) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580376 0.94 HSD17B1 (0.32) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580297 0.94 AHR (0.32) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL25578862 0.94 LMNA (0.34) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580334 0.91 NPC1 (0.35) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL25580357 0.91 MCL1 (0.33) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580232 0.90 KDM4E (0.33) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580194 0.90 KDM4E (0.34) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL25580649 0.90 ALDH1A1 (0.34) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL25580214 0.90 NPC1 (0.35) MAPTALDH1A1KDM4EHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 MAPT 2089/4885ALDH1A1 449/4885KDM4E 2752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback